Nonetheless, the subset of isolated large EpCAM+, CK+ tdEVs from blood of cancer patients has a similar prognostic power to CTCs in metastatic prostate, breast, colorectal, and nonsmall cell lung cancer patients (Figure 12) and can complement CTCs in the CellSearch assay. The gene discussed is EPCAM; the disease is cancer.